| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.092 | 0.04 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.04 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |